MELK is Required for G2/M Phase Progression in Cortical Progenitors: Insights from Rare ASD-Associated Variants [0.03%]
罕见自闭症相关变异提示MELK对于皮层祖细胞G2/M期进程是必需的
Liyang Zhao,Xianjing Li,Kang Yang et al.
Liyang Zhao et al.
Maternal embryonic leucine zipper kinase (MELK) is a cell cycle regulator, yet its role in embryonic cortical development remains unclear. We identified ultra-rare, predicted loss-of-function MELK variants in ASD individuals, prompting this...
Correction: Inhibition of Ferroptosis Alleviates Early Brain Injury After Subarachnoid Hemorrhage In Vitro and In Vivo via Reduction of Lipid Peroxidation [0.03%]
纠正：通过减少脂质过氧化抑制铁死亡可缓解实验性动脉瘤性蛛网膜下腔出血后的早期脑损伤
Yuchen Li,Yao Liu,Pei Wu et al.
Yuchen Li et al.
Published Erratum
Cellular and molecular neurobiology. 2026 Apr 13;46(1):82. DOI:10.1007/s10571-026-01727-5 2026
Cell Therapy for Spinal Cord Injury: Mechanistic Insights and Translational Challenges [0.03%]
脊髓损伤的细胞治疗：机制见解与转化挑战
Duc-Hiep Bach,Bui Van Giang,Thanh Liem Nguyen
Duc-Hiep Bach
Does Enriched Environment Improve Chronic Immobilization Stress-Induced Cognitive and Behavioral Changes in Adult Male Rats? [0.03%]
丰富环境能否改善慢性束缚应激大鼠的认知和行为损伤？
Mona A Mohammed,Amira S Ahmed,Fatma M M Salem et al.
Mona A Mohammed et al.
Chronic stress induces detrimental effects on cognition, behavior, and hippocampal integrity. An enriched environment (EE) has been shown to enhance learning and memory; however, its role against chronic immobilization stress (CIS)-induced ...
Kun Miao,Meng Meng,Liangjing Liu et al.
Kun Miao et al.
Axonal degeneration and demyelination are common pathological phenotypes in central nervous system (CNS) injury and degenerative diseases. Axonal and myelin diseases have generally been considered distinct phenomena, although our knowledge ...
Exploring the Association of Genetic Determinants of SIRT1, MTHFR, and MIR146A Gene Polymorphism with the Ischemic Stroke Predisposition: A Case Control Study [0.03%]
SIRT1、MTHFR和MIR146A基因多态性与缺血性卒中遗传易感性的病例对照研究
Abdullah Hamadi,Rashid Mir,Osama M Al-Amer et al.
Abdullah Hamadi et al.
Correction: Mitochondrial Transplantation Therapy for Ischemic Stroke: Progress and Challenges [0.03%]
纠正：缺血性卒中线粒体移植治疗：进展和挑战
Zhi-Hong Zhao,Xue-Ling Yang,Zi-Wei Lu et al.
Zhi-Hong Zhao et al.
Published Erratum
Cellular and molecular neurobiology. 2026 Apr 6;46(1):79. DOI:10.1007/s10571-026-01721-x 2026
Narrative Review "Dual Frontiers in Neurodegeneration: Pharmacological Synergies and Divergences in Parkinson's Disease and Type 2 Diabetes Mellitus" [0.03%]
“神经退行性疾病的双重前沿：帕金森病和2型糖尿病药物的协同作用与差异”的叙述性回顾论文
Omnya A Sharallah,Vishnu Malakar,Ahmed E Salama et al.
Omnya A Sharallah et al.
A Hypothesis-Generating Pharmacologic Profile for Sargramostim Treatment of Parkinson's Disease [0.03%]
莫索尼定治疗帕金森病的假设生成药理学特征
Susmita Sil,Xiaoqing Du,Samia Akter et al.
Susmita Sil et al.
Epigenetic Mechanisms Regulating Ferroptosis in Ischemic Stroke: From Pathogenesis to Therapeutic Targets [0.03%]
缺血性卒中铁死亡的表观遗传调控机制：从发病机制到治疗靶点
Jiale Gan,Xinyi Yang,Jianan Wu et al.
Jiale Gan et al.
Ischemic stroke (IS) remains a leading cause of death and disability worldwide; however, effective neuroprotective therapies are lacking. Ferroptosis, an iron-dependent form of regulated cell death driven by lipid peroxidation, has emerged ...